Il-6 via the membrane receptor activates non-receptor tyrosine kinases including JAK2, which induce the JAK2/STAT3 cascade for angiogenesis and tumor enlargement because of regulating progression of the cell cycle. This evidence concerns the gene IL6 and neoplasm.